Product Code: ETC052449 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Philippines biologics market is expected to grow at a CAGR of 7.1% from 2020 to 2026, driven by the increasing prevalence of chronic diseases and growing demand for innovative therapies in the country. The rising prevalence of cancer, HIV/AIDS, and other infectious diseases are key drivers propelling market growth. Additionally, technological advancements in biologics production such as gene-based therapeutics would create potential opportunities for this market over the forecast period. Furthermore, investments by public sector bodies on healthcare infrastructure have been observed across several countries in Southeast Asia including Malaysia and Indonesia which is also beneficial to the Philippine bio-market???s growth prospects
COVID 19 has had an adverse effect on various sectors worldwide including the Healthcare Industry due to supply chain disruptions caused by lockdowns as well as travel restrictions among others. With regards to the Philippines Biologics Market specifically; it was predicted that during Q2 2020 there will be a slow down in terms of new drug launches or even product updates related activities owing to cost cutting efforts implemented by major players operating within this space because of cash flow issues arising due to lost revenues amidst pandemic induced economic instability globally . However with government initiatives such as ???One Hospital Command Centers??? (OHCC) , wherein national hospitals were equipped with necessary supplies like ventilators etc., health care industry managed its operations efficiently despite pandemic related challenges thus creating future opportunities for both companies manufacturing bio products & services alike
Increasing Investments In Research & Development For Novel Therapies: Pharmaceutical firms globally are investing heavily into R&D involving novel treatments leveraging advanced biological sciences such as genomics and proteomics which will propel market growth over coming years
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Biologics Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Biologics Market Revenues & Volume, 2020 & 2030F |
3.3 Philippines Biologics Market - Industry Life Cycle |
3.4 Philippines Biologics Market - Porter's Five Forces |
3.5 Philippines Biologics Market Revenues & Volume Share, By Source, 2020 & 2030F |
3.6 Philippines Biologics Market Revenues & Volume Share, By Product Type, 2020 & 2030F |
3.7 Philippines Biologics Market Revenues & Volume Share, By Diseaseย Category, 2020 & 2030F |
3.8 Philippines Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2020 & 2030F |
4 Philippines Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Biologics Market Trends |
6 Philippines Biologics Market, By Types |
6.1 Philippines Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Philippines Biologics Market Revenues & Volume, By Source, 2020-2030F |
6.1.3 Philippines Biologics Market Revenues & Volume, By Microbial, 2020-2030F |
6.1.4 Philippines Biologics Market Revenues & Volume, By Mammalian, 2020-2030F |
6.1.5 Philippines Biologics Market Revenues & Volume, By Others, 2020-2030F |
6.2 Philippines Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2020-2030F |
6.2.3 Philippines Biologics Market Revenues & Volume, By Vaccines, 2020-2030F |
6.2.4 Philippines Biologics Market Revenues & Volume, By Recombinant Proteins, 2020-2030F |
6.2.5 Philippines Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2020-2030F |
6.2.6 Philippines Biologics Market Revenues & Volume, By Others, 2020-2030F |
6.3 Philippines Biologics Market, By Diseaseย Category |
6.3.1 Overview and Analysis |
6.3.2 Philippines Biologics Market Revenues & Volume, By Oncology, 2020-2030F |
6.3.3 Philippines Biologics Market Revenues & Volume, By Infectious Diseases, 2020-2030F |
6.3.4 Philippines Biologics Market Revenues & Volume, By Immunological Disorders, 2020-2030F |
6.3.5 Philippines Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2020-2030F |
6.3.6 Philippines Biologics Market Revenues & Volume, By Hematological Disorders, 2020-2030F |
6.3.7 Philippines Biologics Market Revenues & Volume, By Others, 2020-2030F |
6.4 Philippines Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Philippines Biologics Market Revenues & Volume, By Outsourced, 2020-2030F |
6.4.3 Philippines Biologics Market Revenues & Volume, By In-house, 2020-2030F |
7 Philippines Biologics Market Import-Export Trade Statistics |
7.1 Philippines Biologics Market Export to Major Countries |
7.2 Philippines Biologics Market Imports from Major Countries |
8 Philippines Biologics Market Key Performance Indicators |
9 Philippines Biologics Market - Opportunity Assessment |
9.1 Philippines Biologics Market Opportunity Assessment, By Source, 2020 & 2030F |
9.2 Philippines Biologics Market Opportunity Assessment, By Product Type, 2020 & 2030F |
9.3 Philippines Biologics Market Opportunity Assessment, By Diseaseย Category, 2020 & 2030F |
9.4 Philippines Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2020 & 2030F |
10 Philippines Biologics Market - Competitive Landscape |
10.1 Philippines Biologics Market Revenue Share, By Companies, 2023 |
10.2 Philippines Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |